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INTRODUCTION
Vertebrate neurons are typically generated in excess
numbers over their postsynaptic targets, and the supernu-
merary cells are later culled until an appropriate match
between innervation and target field size is achieved (Cowan
et al., 1984). This elimination of excess neurons is thought
to occur by competition for limiting quantities of survival
factors, called neurotrophins, secreted by the target (Purves
and Lichtman, 1985). If excess neurotrophin molecules are
experimentally introduced to the system, neurons that ordi-
narily would have died are rescued (Angeletti et al., 1971;
Hamburger et al., 1981). Conversely, if the concentration of
neurotrophins is experimentally reduced (for example, by
using blocking antibodies), then neurons that ordinarily
would have survived, die (Levi-Montalcini and Booker,
1960; Rohrer et al., 1988). Such fine tuning of cell number
can occur because these neurons are apparently programmed
to undergo apoptosis in the absence of neurotrophic support
(Martin et al., 1988). This process of target control of
neuronal survival is fundamental to vertebrate neurogenesis,
but is not yet adequately modeled by invertebrate systems
amenable to genetic analysis (although programmed cell
death has been genetically demonstrated in these systems
(Ellis et al., 1991)).
Substantial progress has recently been made in under-
standing the molecular basis of trophic control of neuronal
survival. Neurotrophins comprise a family of four distinct
genes, all of which encode proteins structurally related to
Nerve Growth Factor (NGF) (Levi-Montalcini and
Angeletti, 1968), the first neurotrophin to be purified,
seque ced and cloned. Purification and sequencing of the
second neurotrophin, Brain-Derived Neurotrophic Factor
(BDNF) (Leibrock et al., 1989) led to the isolation, via
homology cloning, of neurotrophins 3 and 4/5 (NT-3 and
NT-4/5) (for review, see Thoenen, 1991). Studies in cell
cult re have demonstrated that each of these neurotrophins
supports distinct but overlapping classes of neurons. This
diversity of action is reflected in the distinct expression
patterns exhibited by these genes in vivo (Maisonpierre et
al., 1990a). 
The molecular diversity of neurotrophins is mirrored by
a co responding diversity of their receptors. Neurotrophins
interact with two structurally distinct classes of receptors on
the c ll surface: a member of the trk family of receptor
ty osine kinases; and a low-affinity transmembrane receptor
alled p75. All of the neurotrophins interact with p75
(R driguez-Tébar et al., 1990), but each of them displays
disti ct high-affinity interactions with a member of the trk
family (for review, see Bothwell, 1991). NGF interacts
specifica ly with trkA, BDNF interacts with trkB, NT-3
interacts with trkC (and to a lesser extent with trkB and
trkA) and NT-4/5 interacts primarily with trkB (for review,
see Meakin and Shooter, 1991). The interaction of neu-
rotr phins with their receptors is thought to provoke an
intracellular signalling cascade involving the c-rasGTPase
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Sympathetic neurons require NGF for survival, but it is
not known when these cells first become dependent on
neurotrophic factors. We have examined in vitromitot-
ically active sympathetic neuroblasts immuno-isolated
from different embryonic stages, and have correlated
this functional data with the expression of neurotrophin
receptor mRNAs in vivo. Cells from E14.5 ganglia are
supported by neurotrophin-3 (NT-3) in a serum-free
medium, but not by NGF; NT-3 acts as a bona fide
survival factor for these cells and not simply as a
mitogen. By birth, sympathetic neurons are well-
supported by NGF, whereas NT-3 supports survival only
weakly and at very high doses. This change in neu-
rotrophin-responsiveness is correlated with a reciprocal
switch in the expression of trkC and trkA mRNAs by
sympathetic neuroblasts in vivo. These data suggest that
neurotrophic factors may control neuronal number at
earlier stages of development than previously antici-
pated. They also suggest that the acquisition of NGF-
d pendence may occur, at least in part, through the loss
of receptors for these interim survival factors.
Key words: neuroblast, sympathetic neuroblast, NGF,
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(Kremer et al., 1991), analagous to the pathways recently
described for signal transduction through receptor tyrosine
kinases via genetic analysis in Caenorhabditis elegansd
Drosophila(for reviews, see Rubin, 1991; Sternberg and
Horvitz, 1991).
Relatively little is understood about when and how devel-
oping neurons become dependent upon trophic support
during development. Peripheral sensory and sympathetic
ganglia have served as useful model systems for the inves-
tigation of these issues because of their relative simplicity
and experimental accessibility, and because the neu-
rotrophins for these ganglia have been relatively well-
defined. Sympathetic neurons are thought to be supported
primarily by NGF, whereas sensory neurons are supported
by NGF, BDNF and, to some extent, NT-3 (Chun and
Patterson, 1977; Levi-Montalcini and Angeletti, 1963;
Lindsay et al., 1985; Maisonpierre et al., 1990b). In
principle, neurons could survive independently of trophic
factors until they began to innervate their targets, at which
point they would acquire such a dependence. Alternatively,
neurons and their precursors could be constitutively pro-
grammed to die unless supported by trophic factors of one
sort or another, in which case the nature of the trophic factor
and its source of production might change as the develop-
ing neuron reached its target.
Recent in situ hybridization experiments have revealed
that some neurotrophin mRNAs are expressed in embryonic
sympathetic ganglia, raising the possibility that these factors
could play a role at early stages of neurogenesis (Schecter-
son and Bothwell, 1992). Studies of embryonic mouse and
chick sympathetic and sensory neurons in vitro have
suggested that these cells survive independently of NGF at
early developmental stages (Coughlin and Collins, 1985;
Ernsberger et al., 1989; Vogel and Davies, 1991). However,
these studies have been performed using heterogeneous
mass cultures and serum-containing culture media, both of
which could provide sources of exogenous growth factors.
Here we have investigated the trophic requirements of
immuno-isolated sympathetic neuroblasts grown in a serum-
free defined medium. We find that these cells are initially
supported by NT-3, but not by NGF. Subsequently, the cells
acquire NGF responsiveness and are supported much less
well by NT-3. This switch in neurotrophin responsiveness
in vitro is correlated with a reciprocal switch in trkC and
trkA mRNA expression in vivo. These data indicate that
sympathetic neuroblasts require interim survival factors
while they are still proliferating and before they become
NGF dependent. NGF dependence is achieved through the
induction of expression of NGF receptors and the extinction
of expression of receptors for the interim trophic factor NT-
3.
MATERIALS AND METHODS
Isolation and culture of primary rat sympathetic
precursor cells and neurons
Sympathetic ganglia were dissected from embryonic Simonson
white rats (Simonson Laboratories) at 14.5 and 19.5 days of
gestation (assuming the date of the plug as 0.5). The sympathetic
chains were removed from the cervical to the lumbar region and
w re dissociated by treating the ganglia with 1.5 mg/ml collage-
nase (Worthington) and 1.0 mg/ml elastase (Sigma) made up in
Hepes-buffered SMEM (HMEM-Gibco) for 30 minutes at 37˚C. A
small aliquot of cells was reserved for use as a negative control for
antibody staining, and the rest of the preparation was treated with
the B2 antibody (1:1 dilution of a hybridoma supernatant) for 30
minutes at room temperature. The cells were washed once and
further incubated with a fluorescein-conjugated goat anti-mouse
IgM secondary antibody (TAGO) for 30 minutes at room temper-
ature. B2-positive cells were isolated on a Epics Elite Fluores-
cence-Activated-Cell Sorter (Coulter). Viable cells were counted
on a hemacytometer by trypan blue exclusion (Gibco) and plated
into the wells of 24-well dishes (Fisher) that had been treated with
poly-D-lysine (Biomedical Technologies) and laminin (Collabora-
tive Research). The B2+ sympathetic precursor cells were grown
in a defined, serum-free medium that was a modification of L15N2
medium (Wolinsky et al., 1985) and consisted of L15CO2 con-
taining 1:1:2 (glutamine/penicillin-streptomycin/gluocse) and
fresh vitamin mix (FVM) (Hawrot and Patterson, 1979) with the
following additions: 100 mg/ml transferrin (Sigma), 16 mg/ml
putrescine (Sigma), 20 nM progesterone (Sigma) and 30 nM
selenious acid (Aldrich). Note that this medium does not contain
insulin.
Neonatal rat sympathetic neurons were obtained from the
superior cervical ganglia (SCG) of postnatal day 1 Simonson white
rats. The ganglia were dissected out and dissociated with 5.0 mg/ml
dispase (BMB) and 1.0 mg/ml collagenase made up in Hepes-
buffered SMEM for 1 hour at 37˚C. The cells were triturated
through a fire-polished pasteur pipette and were preplated onto an
untreated 60 mm tissue culture dish to permit the attachment of flat
cells in the preparation. After 2 hours the enriched neuron popula-
tion was removed and plated onto the wells of 24-well dishes that
had been coated with poly-D-lysine and laminin. The neurons were
cultured in the defined, serum-free medium described above.
Cell recovery and proliferation assays
B2+ sympathetic precursor cells or neonatal SCG neurons were
plated at a density of 2500 cells/well in 24-well dishes. After 2-3
hours factors were added to the cultures and strips of cells were
counted in each well and the total number of attached cells calcu-
lated. Unless otherwise noted, NGF (UBI) and purified, recombi-
nant NT3 (provided by George Yancopoulos, Regeneron Pharma-
ceuticals, Tarrytown, NY) were used at 25 ng/ml and
aurintricarboxylic acid (ATA, Sigma) at 25 mM. The cells were
incubated at 37˚C in a humidified, 5% CO2 atmosphere. After 24
hours, the cells were fixed by gently underlayering 0.5 ml of
HMEM containing 3.7% formaldehyde, 5% sucrose, 20% FBS and
0.02% azide. 
Several procedures were employed to minimize sampling error
in the cell-recovery assays. First, determinations in each well or
plate at the end of the experiment were normalized to the number
of cells initially present on hat same plate the beginning of the
experiment (‘percentage cell recovery’), thereby eliminating well-
to-well variations in initial plating efficiencies. Second, all of the
viable cells (distinguished by their round, phase-bright morphol-
ogy) in each well or plate were counted at the end of the experi-
ment, rather than simply counting cells in a few selected micro-
scopic fields. This procedure minimizes sampling errors due to
uneven cell distribution which compromises counts based on such
selected fields. Typical determinations were 600-800 cells per well
in NT-3 and 200-300 cells per well in control or NGF (at E14.5).
All determinations were made in triplicate for each condition in
each experiment. Thus at least 2000-3000 cells in toto were
counted for each experiment. We refer to ‘percentage cell
recovery’ as our metric, rather than ‘percentage cell survival,’
bec us  the cell population is proliferating and the relative contri-
butions of cell division and survival to the total number of cells
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present at the end of the incubation are not distinguished by such
assays. Each experiment reported was performed independently at
least two times.
To assess the mitogenic effect of various factors, E14.5 sympa-
thetic precursor cells were plated as described above and after 3
hours, 25 ng/ml NT3 or 10 ng/ml bFGF (R&D Systems) was added
and plating counts were determined. 8 hours before the end of the
24 hour culture period, BrdU (BMB) was added to a final concen-
tration of 10 m M. 8 hours later the cells were fixed for 30 minutes
at - 20˚C in 70% ethanol and stained for BrdU (Raff et al., 1988).
Cells were washed three times with PBS to remove the ethanol and
then treated for 10 minutes with 2 N HCl. The wells were again
washed with PBS and treated an additional 10 minutes with 0.1 M
Na2B4O7 ·10H2O. After further washing, the cells were incubated
for 1 hour at room temperature with a 1:20 dilution of mouse anti-
BrdU (DAKO) and then for 1 hour with fluorescein-conjugated
goat anti-mouse IgG (TAGO, 1:100). The cells were counter-
stained with DAPI (1 mg/ml for 5 minutes at room temperature)
in order to visualize the nuclei. An in situ MTT assay (Barres et
al., 1992) was carried out on sister cultures to determine the per-
centage of viable cells at the time of fixation, because the harsh
pretreatments (ethanol fixation and acid extraction) used in the
BrdU-labeling assay eliminated the good cell morphology used to
assess cell viability in other experiments. The MTT assay was
performed in sister cultures rather than as a double label with BrdU,
because the MTT reaction product was solubilized by the fixation
conditions used for the BrdU assay. 30 minutes before the end of
the 24 hour culture period, MTT (Sigma) was added to final con-
centration of 0.5 mg/ml (Mosmann, 1983). After 30 minutes at
37˚C, the cells were fixed with 3.7% formaldehyde, the nuclei
stained with DAPI and the percentage of DAPI-stained cells that
showed the black MTT reaction product was determined for each
condition. This number was then used to calculate the total number
of viable cells in the BrdU-labeled cultures. Percentage cell
recovery in the BrdU-labeled cultures was estimated dividing this
number by the number of cells present after 3 hours (to correct for
well-to-well variations in plating). While these procedures may
introduce systematic errors that affect the magnitude of cell
recovery or viability calculated, they should not affect a compari-
son of conditions between cultures processed and analyzed in the
same way.
Immunocytochemistry
For immunocytochemical labeling, cells were fixed in HMEM con-
taining 3.7% paraformaldehyde, 5% sucrose, 0.02% azide. Perme-
abilization was carried out using 0.1% Nonidet P-40 in phosphate-
bufffered saline (PBS) containing 1% Normal Goat Serum, for 20
minutes at room temperature, prior to incubation with primary
antibody. Monoclonal antibody to the 160´ 103Mr subunit of neu-
rofilament was from Sigma Chemicals. Staining was visualized
using a FITC-conjugated goat anti-mouse IgG (TAGO,
Burlingame, CA). Neurotag is a RITC-labeled tetanus toxoid
(Boehringer-Mannheim, Inc.) and was used to surface label
formaldehyde-fixed neurons. Labeling was carried out for 1 hour
at room temperature using 5 m g/ml Neurotag in PBS containing
0.1% bovine serum albumin.
Nonradioactive in situ hybridization
In situ hybridization with digoxigenin-labeled cRNA probes was
performed on frozen sections of paraformaldehyde-fixed embryos,
using a modification of the procedure developed for Xenopus
embryos by Harland (Harland, 1991). A detailed protocol is
available on request. Briefly, following pretreatments (Proteinase
K, postfixation, acetic anhydride) sections were dehydrated
through an ethanol series and air dried. They were then prehy-
bridized for 3-4 hours at 60°C. Hybridization was carried out for
12-16 hours using 1-2 m g/ml of probe, in plastic slide mailers con-
Fig. 1. E14.5 sympathetic ganglia express trkC but not trkA
mRNAs. Nonradioactive in situ hybridization to consecutive serial
transverse sections through the trunk region is shown, using the
probes indicated on the panels. Note the location of the
sympathetic ganglia (SG) revealed by SCG10 expression (A);
these ganglia express trkC (B) but not trkA (C). The expression of
trkC in sympathetic ganglia at this stage (B) is reproducibly lower
than that observed in dorsal root ganglia (DRG) in the same
sections (arrowhead, B). As previously reported (Martin-Zanca et
al., 1990) trkA is abundantly expressed by dorsal root ganglia
(DRG) neurons (compare A and C, upward arrowheads). Bar, 125
m m.
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taining sufficient probe solution to immerse the part of the slides
containing the sections. Probes used in this way could be re-used
up to six or seven times without appreciable loss of signal. The
anti-digoxigenin antibody (BMB) was preabsorbed with dissoci-
ated tissue from a mixture of fixed embryos from stages E12.5-
E13.5. The alkaline phosphatase reaction product was developed
using the NBT/BCIP reagents. Sections were prewashed with lev-
amisole, and development was carried out for 2-20 hours
depending upon the abundance of the target mRNA. Wash buffers
containing CHAPS detergent were re-used to economize. Probes
used for in situ hybridization were: trkA, a 464 bp insert derived
from the extracellular domain of the mouse trkA cDNA clone in
plasmid pDM97; trkB, a 483 bp insert derived from the extracel-
lular domain of the mouse trkB cDNA clone in plasmid pFRK16;
trkC, an approx. 2 kb cDNA containing the extracellular and trans-
membrane domains in the plasmid pRtrkc8.
RESULTS
Embryonic sympathetic neuroblasts express trkC
but not trkA mRNA
We sought to determine potential neurotrophic factors for
sympathetic neuron precursors by examining the expression
of neurotrophin receptor mRNAs in rat sympathetic ganglia
during embryonic development. Initially we assayed for the
xpre sion of trkA mRNA in embryonic day 14.5 (E14.5)
rat sympathetic ganglia by non-radioactive in situhybridiz-
ation with a cRNA probe. As a positive control, adjacent
serial sections were hybridized with a probe for SCG10, a
pan-neuronal marker (Stein et al., 1988), to reveal the dis-
tribution of neuronal cell bodies in dorsal root and sympa-
thetic ganglia (Fig. 1A). At this stage, the trkA probe did not
hybridize to neuronal cells in the sympathetic ganglia,
although trkA message was clearly detected in the DRG
where it was resticted to large neuronal cell bodies (Fig. 1C).
Giv n that early sympathetic precursor cells do not
express NGF receptor mRNA, we asked whether these cells
express mRNAs encoding receptors for other neurotrophic
factors. Neurotrophin 3 (NT-3) is a member of the neu-
rotrophin family and is widely expressed in the periphery
(Maisonpierre et al., 1990a) as well as in embryonic sym-
pathetic ganglia (Schecterson and Bothwell, 1992). We
therefore examined the expression of trkC, the NT-3
receptor. In contrast to trkA mRNA, trkC mRNA was
clearly detectable in E14.5 sympathetic ganglia (Fig. 1B,
arrowhead). Close comparison of the trkC and SCG10
expression patterns in adjacent serial sections, with the
increased cellular resolution afforded by the non-radioactive
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Fig. 2.Higher magnification view of neurotrophin receptor mRNA expression in E14.5 trunk sympathetic ganglia. Consecutive serial
transverse sections hybridized with probes for SCG10 (A), trkB (B), trkC (C) and trkA (D) are shown. Note that the trkB-expressing cells
exclude the region of the ganglion primordium occupied by SCG10-expressing neuroblasts (A, arrow; cf. B, open arrow). By contrast,
trkC mRNA expression is detected within the SCG10-expressing region (C, arrow), as well as in a strip of cells in the adjacent
mesenchyme. No expression of trkA mRNA is detected (D). Bar, 32 m m.
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technique, indicated that trkC was indeed expressed by neu-
roblasts in the developing ganglia (compare Fig. 2A and C),
while trkA was not detected (Fig. 2D). We cannot exclude
that trkC is also expressed in glial precursors, although it
cannot be exclusively expressed in these cells as they have
a different distribution in the ganglia from the neuroblasts
(Guillemot et al., unpublished data). By contrast, the
expression of trkB (previously reported in embryonic sym-
pathetic ganglia, Schecterson and Bothwell, 1992) appeared
restricted to non-neuronal cells circumscribing the condens-
ing ganglionic neuroblasts (Fig. 2B). These cells may be
mesenchymal cells or they may be glial precursors
(Guillemot, et al., unpublished data). The specificity of our
non-radioactive in situ hybridization procedure is demon-
strated by the fact that four distinct probes gave four distinct
expression patterns under our high-stringency annealing
conditions.
NT-3 but not NGF acts as a survival factor for
isolated E14.5 sympathetic neuroblasts
The expression pattern of neurotrophin receptor mRNAs in
early rat sympathetic ganglia suggested that sympathetic
precursor cells at this stage may respond to NT-3 but not to
NGF. To test this hypothesis, we isolated an antigenically
homogeneous population of sympathetic precursor cells
from E14.5 rat embryos using a monoclonal antibody called
B2, and examined its responsiveness to NGF and NT-3 in
vitro. B2 detects a cell surface glycolipid (J. Dodd, personal
communication) expressed specifically in most or all neu-
roblasts of sympathetic ganglia beginning at E13.5-E14.5,
the time that progenitors in these ganglia commit to a
neuronal fate (Anderson and Axel, 1986; Anderson et al.,
1991). FACS isolation of B2+ cells from E14.5 embryos
yielded a 92% pure population, as assessed by counter-
staining with DAPI (Fig. 3A,B). In addition, 96% of isolated
B2+cells also expressed the tetanus toxin receptor on their
surface (Fig. 3C,D), confirming that these cells exhibit a
neuronal phenotype. Furthermore, B2+c lls when plated in
defined, serum-free medium rapidly extend long, neurofila-
ment-containing neurites in the absence of any added growth
factors (Fig. 3E). These cells, however, lack the large cell
bodies characteristic of mature sympathetic neurons and are
still mitotically active (see below), indicating that they are
not neurons, but rather neuroblasts. The properties of these
cells are therefore similar to those of B2+ cells previously
isolated from E14.5 adrenal glands (Anderson and Axel,
1986), and also resemble those of sympathetic neuroblasts
from embryonic chick ganglia (Rohrer and Thoenen, 1987).
When purified E14.5 B2+ cells were plated in defined,
serum-free medium in the absence of growth factors, the
cells elaborated long neurites but showed poor survival (Fig.
4A, Con). In the presence of NGF, cell recovery after 24
hours was not significantly different than in the control
condition (Fig. 4A, NGF), consistent with our failure to
detect trkA mRNA in these cells by in situ hybridization in
vivo. When NT-3 was added to the growth medium at 25
ng/ml, however, a significant increase in cell recovery was
seen (Fig. 4A,B, NT-3). In addition, the cells appeared
healthier as judged by morphological criteria (not shown).
Dose-response experiments (see below, Fig. 8B) indicated
that half-maximal activity of NT-3 on these cells was
obtai d at 1 ng/ml. In control medium, on average 35% cell
recovery was obtained. Cell recovery continued to decline
with longer incubations in control medium, suggesting that
s me cells simply take more time to die. However, some
E14.5 B2+cells may survive for short periods independent
of exogenous NT-3. Whether this reflects a true neu-
rotrophin independence, or rather the production of endoge-
nous neurotrophins by the cells, remains to be determined.
In any case, at E14.5 a large proportion of sympathetic
neuro  precursor cells demonstrate a functional response to
NT-3, consistent with the detection of trkC mRNA in vivo
by in itu hybridization. B2+ cells isolated at E15.5 also
showed a response to NT-3 (not shown). 
The increased number of sympathetic neuroblasts
recovered in the presence of NT-3 raised the possibility that
these cells may be dependent upon NT-3 for survival (see
below). To determine whether these cells undergo apoptotic
cell death in the absence of added growth factors, we
examined the effect of aurintricarboxylic acid (ATA), which
inhibits apoptotic cell death in sympathetic neurons and
PC12 cells deprived of NGF (Batistatou and Greene, 1991).
When B2+cells were cultured in the presence of ATA, there
was an increased recovery of cells after 24 hours even in the
absence of NT-3 (Fig. 4B). The number of cells recovered
after treatment with ATA was similar to that obtained with
NT-3, suggesting that B2+cells indeed are programmed to
undergo apoptosis in the absence of growth factors.
Since E14.5 B2+cells are mitotically active, NT-3 could
ct to increase the recovery of these cells in several
different ways: it could act as a mitogen, as a survival
factor, or as both. We therefore examined the effects of NT-
3 on the proliferation of E14.5 B2+ cells using a BrdU-
labelling assay. We compared the effect of NT-3 to that of
bFGF (basic fibroblast growth factor), a known mitogen for
the sympathoadrenal lineage (Birren and Anderson, 1990;
Claud  et al., 1988; Stemple et al., 1988). While FGF stim-
ulated BrdU incorporation (Fig. 5A), the percentage
recovery of viable cells after 24 hours in this condition was
not significantly different from control (Fig. 5B). This
result is consistent with the idea that bFGF acts as a mitogen
but not as a survival factor for sympathoadrenal lineage
cells (Birren and Anderson, 1990; Stemple et al., 1988).
When B2+precursor cells were treated with NT-3, the stim-
ulation of BrdU incorporation was similar to (or slightly
lower than) that obtained with bFGF (Fig. 5A). However,
thes  same NT-3-treated cultures showed a clear increase
in the recovery of viable cells, in contrast to bFGF-treated
or control cultures (Fig. 5B) (although the apparent
magnitude of this increase was not as great as in other
experiments, due to cell losses occurring during washes in
the BrdU-labeling procedure). 
These data suggest that the increased cell recovery
obtained with NT-3 is unlikely to be explained by a purely
mitogenic action, otherwise the percentage cell recovery
w uld have been similar to that obtained with bFGF. While
we cannot rule out a partial mitogenic activity for NT-3, our
data suggest that this neurotrophin is also likely to act as a
survival factor for B2+cells. That the survival of these cells
can be promoted independently of mitogenic stimulation is
shown by the ability of ATA, which is not a mitogen, to
promote increased recovery of the cells (see Fig. 4B, above).
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Indeed, the apparent stimulation of BrdU incorporation by
NT-3 (Fig. 5A) could reflect a purely trophic effect on a sub-
population of proliferating cells, rather than a mitogenic
effect. 
Further evidence for a trophic role for NT-3 comes from
experiments in which cohorts of untreated or NT-3-treated
B2+ precursors cells were identified at clonal density and
then followed. After a 72 hour culture period, only 18% of
control colonies had survived (n=45 colonies followed),
while 40% of colonies in NT-3 had survived (n=50 colonies
followed). (Overall survival in these experiments was
reduced due to the low plating densities used for single cell
tracking). If NT-3 were acting solely as a mitogen, then the
num er of colonies recovered in control and NT-3 should
hav  been identical, but the colonies should have been larger
in NT-3 (i.e., a larger percentage of colonies should have
had >1 cell). However, as indicated above, colony recovery
was clearly greater in the presence of the neurotrophin
(although colony size was slightly greater as well).
Moreover, while the majority of surviving cells divided at
east once during the entire cohort experiment, only about
half of the cells had divided once during the first 24 hours
in the presence of NT-3. This extent of proliferation is insuf-
fi cient to account for the two- to three-fold stimulation of
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Fig. 3. Characterization of B2-
isolated cells. Sympathetic
neuroblasts isolated by FACS using
monoclonal antibody B2 (Anderson
and Axel, 1986; Anderson et al.,
1991) from E14.5 sympathetic
ganglia. B2-positive cells (B,D)
were counterstained immediately
after sorting with either DAPI (A)
or Neurotag (C) (which detects the
tetanus toxin receptor, a surface
marker for most or all neurons).
After culturing for 24 hours in
serum-free defined medium, most
(approx. 70%) of the cells had died;
however, the remaining cells bore
long, neurofilament-positive
neurites (E). Arrow in E indicates a
process-bearing cell undergoing
mitosis as revealed by DAPI
staining.
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cell recovery promoted by NT-3 in mass culture experi-
ments, again supporting the conclusion that NT-3 acts as a
survival factor. 
Reciprocal regulation of neurotrophin
responsiveness during sympathetic development
E14.5 sympathetic neuroblasts express trkC mRNA and
respond to NT-3; in contrast, neither trkA mRNA nor a bio-
logical response to NGF can be detected in these cells.
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Fig. 4.E14.5 B2+ cells respond to NT-3. (A) The percentage cell
recovery in the indicated conditions is calculated by normalizing
the total number of cells recovered after 24 hours of culture to the
starting number of cells in each culture (see Experimental
Procedures). This normalization controls for well-to-well
variations in the initial plating efficiency. The values plotted in (A)
represent the mean ± s. e. m. of the average of triplicate
determinations from each of 4-8 independent experiments. For
each determination, all of the cells were counted in a given well
(typically 600-800 cells for NT-3 and 200-300 for control). This
procedure eliminates the sampling error due to uneven cell
distribution inherent in counting random microscopic fields or
strips. Note that NT-3 but not NGF yields an increased cell
recovery over control (asterisk indicates the difference is
s i g n i ficant to P<0.05 by Student’s t- est). (B) One condition
included 25 m M aurintricarboxylic acid (ATA), an inhibitor of
apoptotic cell death in sympathetic neurons and PC12 cells
(Batistatou and Greene, 1991). Note that the percentage cell
recovery in ATA is close to that obtained with NT-3. Bars
represent the mean ± s. e. m. of two independent experiments, each
with triplicate determinations. Asterisks indicate the NT-3 and
ATA conditions are significantly different from control (P<0 . 0 5 ) .
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Fig. 5.NT-3 acts as a survival factor and not simply as a mitogen
for E14.5 B2+ cells. (A) Cultures grown in the indicated factors
were pulsed with BrdU for the final 8 hours of a 24 hour culture
period and developed using an anti-BrdU antibody. The percentage
of DAPI+nuclei labeled by BrdU was determined. The error bars
represent the mean ± s. e. m. of triplicate determinations. (B) The
p rcentage recovery of viable (MTT+) cells was measured in sister
cultures and calculated for the cultures labeled with BrdU in A.
(BrdU and MTT staining could not be performed on the same
plates due to fixation incompatibility; see Experimental
Procedures). The numbers in parentheses indicate the average total
number of MTT+cells calculated for each condition; the bars
repr sent this number normalized to the number of cells present 3
hours after plating. Note that NT-3 promotes higher cell recovery
than bFGF (B) even though the latter is if anything a stronger
mitogen (A). The apparent percentage cell recovery in all
conditions is depressed in this experiment, because the extensive
washings employed for BrdU labeling caused cell detachment.
However, within this experiment, the relative effects of NT-3 and
bFGF on viability versus BrdU incorporation should be directly
comparable. Similar results were obtained in two independent
r petitions of the experiment. Asterisk indicates the NT-3
condition is significantly different from control (P<0 . 5 ) .
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However, neonatal sympathetic neurons respond to, and are
dependent upon, NGF for survival. This implies that sym-
pathetic precursors must acquire the ability to respond to
NGF during development. Furthermore, if mature sympa-
thetic neurons are dependent solely upon NGF for survival,
then either the cells must lose NT-3 responsiveness as they
develop, or NT-3 must become unavailable to the mature
cells. To examine changes in neurotrophin responsiveness
of sympathetic precursor cellsthrough development, we
first followed the expression of trkA and trkC mRNAs in
ympa hetic ganglia by non-radioactive in situ hybridiz-
ation t E15.5, E16.5, E17.5, E18.5 and E19.5. The results
obtained from E15.5 embryos resembled those at E14.5, in
that trkC mRNA was detectable but trkA mRNA was not
(data not shown). Subsequent to E15.5, the relative levels
of trkA and trkC mRNAs shifted dramatically. TrkA
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Fig. 6.Reciprocal regulation of trkC and trkA mRNAs during later sympathetic development. Consecutive serial transverse sections from
the thoracic region of an E19.5 embryo were hybridized with probes for SCG10 (A,D), trkA (B,E) and trkC (C,F). Nonradioactive
detection was employed to achieve increased cellular resolution. Open arrows (A-C) indicate DRG, solid arrows the sympathetic ganglia.
(D-F) Higher magnification views of the sympathetic ganglia (solid arrows) shown in A-C, respectively. Arrowheads in D-F indicate
blood vessels near the ganglia. Note that trkA but not trkC is expressed in the sympathetic ganglia; the DRG provide an internal positive
control for trkC expression (C, open arrow). TrkA mRNA was first detectable in sympathetic ganglia at E16.5-17.5, a stage when trkC
mRNA is still expressed (not shown). Bar (A-C), 110 m m; (D-F), 40 m m.
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mRNA was occasionally detectable at E16.5 and, by E17.5,
was readily apparent; by contrast trkC mRNA began to
decline after E17.5 (data not shown). By E19.5, the
expression of trkC mRNA was below the limit of detection
(Fig. 6C,F), while trkA mRNA was clearly detectable (Fig.
6B,E). Thus, trkA and trkC mRNAs show reciprocal but
overlapping patterns of expression in developing sympa-
thetic ganglia, suggesting that there may be a switch in neu-
rotrophin responsiveness during sympathetic neuron differ-
entiation. Others have reported recently on the expression
of trk mRNAs in developing rodent embryos (Martin-Zanca
et al., 1990; Ernfors et al., 1992; Klein et al., 1990;
Schecterson and Bothwell, 1992), but the stages analyzed
were not appropriate to observe the reciprocal regulation of
trkA and trkC mRNAs in sympathetic ganglia.
To correlate the changes in trkA and trkC mRNA
expression with the neurotrophin responsiveness of sym-
pathetic neuroblasts, B2+ cells were isolated from E19.5
sympathetic ganglia and their responsiveness to NGF and
NT-3 compared in vitro. By contrast to the results at E14.5
(Fig. 4A), NGF clearly increased the recovery of E19.5 B2+
cells in a 24 hour assay (Fig. 7A) (although 100% cell
recovery was not obtained, suggesting that some B2+c e l l s
may not yet be NGF responsive). These cells were also
supported to some extent by NT-3 (Fig. 7A); however, the
percentage cell recovery obtained was smaller at E19.5
than at E14.5 (compare Fig. 7A and Fig. 4A, NT-3). These
data therefore confirm that the appearance of trkA mRNA,
as detected by in situ hybridization, is correlated with the
appearance of a biological response to NGF in isolated
sympathetic neuroblasts assayed at the same stage in vitro.
While a complementary decline in trkC mRNA expression
is observed, a relatively modest diminution in the respon-
siveness of the B2+cell population to NT-3 is apparent at
the saturating concentrations of neurotrophin used (but see
b e l o w ) .
To examine the effects of NGF and NT-3 on a more
mature population of sympathetic neurons, we used disso-
ciated cultures of neonatal superior cervical sympathetic
ganglia (SCG). Monoclonal antibody B2 could not be used
to isolate these cells, however, as the expression of this
antigen has declined by this stage (Anderson et al., 1991).
As expected from previous studies (Chun and Patterson,
1977; Levi-Montalcini and Angeletti, 1963), NGF was suf-
ficient to support the survival of most neonatal SCG
neurons, even in our serum-free medium (Fig. 7B). By
contrast, NT-3 at 25 ng/ml had only a weak survival-
promoting effect (Fig. 7B). It supported less than half as
many neurons as did NGF, whereas in the E19.5 B2+
cultures NT-3 supported almost as many cells as supported
by NGF. Moreover, the percentage recovery of neonatal
SCG neurons supported by NT-3 was significantly less
than the percentage recovery of E19.5 B2+cells supported
by the factor (compare Fig. 7A and B, NT-3). The fact that
60-70% of neonatal SCG neurons could be supported by
NGF indicates that the low cell recovery in NT-3 is not
due simply to lowered overall cell viability at this later
a g e .
These data suggest that the responsiveness of sympathetic
neurons to NT-3 indeed declines with development, consis-
tent with the down-regulation of trkC mRNA observed in
vivo. One apparent inconsistency with this conclusion is that
the fold-stimulation over control obtained with NT-3 was
higher for the neonatal SCG population than for the E19.5
B2+ population. However, this difference reflects a higher
baseline survival of the E19.5 cells under control conditions
(compare Figs. 7A and B, Con), suggesting that this less
atur  population, like that obtained from E14.5 embryos
(see above) contains some cells that can survive for short
p riods in the absence of exogenous NT-3.
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Fig. 7.Sympathetic neurons are NGF responsive at E19.5. (A)
Cell recovery assays were performed as described in Fig. 4 on
E19.5 B2+cells, using 25 ng/ml each of NGF and NT-3. Note that
equal or greater cell recovery is obtained with NGF than NT-3,
and that the percentage cell recovery obtained with NT-3 at E19.5
is le s than that obtained using NT-3 with E14.5 B2+cells
(compare with Fig. 4A and B, NT-3). (B) Cell recovery assays
were performed using neonatal SCG neurons in dissociated
culture, grown exactly as described for B2+cells except that
recovery was assayed after 48 hours. Note that the effect of NT-3,
both in relation to NGF and in absolute terms, is weaker than
observed for E19.5 cells (A). The experiments in A and B were
performed three times with similar results.
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Early and late sympathetic neurons exhibit
distinct dosage sensitivities to NT-3
In the foregoing experiments, the responsiveness of devel-
oping sympathetic neuroblasts to NT-3 was examined at
high concentrations of the factor, as in previous studies
(Ernfors et al., 1990; Maisonpierre et al., 1990b; Rosenthal
et al., 1990). Given that these neurons do not express
detectable trkC mRNA in vivo, their response to the neu-
rotrophin in vitro therefore could be a cross-reactivity of
NT-3 with a receptor other than trkC (Cordon-Cardo et al.,
1991; Glass et al., 1991; Soppet et al., 1991). Alternatively,
a subpopulation of SCG neurons could express trkC, or re-
express it under our culture conditions. As a first step to
address this issue, we investigated the dose-response prop-
erties of NT-3 on the survival of neonatal SCG neurons (Fig.
8A). Two main findings emerged from this analysis: first,
the concentration of NT-3 used in the preceding experiments
(25 ng/ml) is subsaturating; second, the dose-response curve
for NT-3 was shifted to the right relative to the profile for
NGF. The concentration of NT-3 required for a half-
maximal response (EC50) was 1.1´ 10- 9 M, as compared to
3.2´ 10- 12M for NGF, a 340-fold difference. The high EC50
for NT-3, as well as the failure to achieve saturating
responses at doses of 10-25 ng/ml, suggested that this neu-
rotrophin may be acting on neonatal SCG neurons through
a receptor distinct from trkC. (By contrast, if the SCG
cultures contained a subpopulation of trkC-expressing
neurons, one would have expected to see a dose-response
profile that saturated at 1-10 ng/ml of NT-3, but which
supported many fewer neurons than NGF even at saturation;
this was not observed). 
To determine whether immature sympathetic neuroblasts
were more sensitive to NT-3, we performed parallel dose-
response experiments using E14.5 B2+cells. In contrast to
the results obtained with neonatal SCG neurons (see above),
the concentration of NT-3 required for a half maximal func-
tional response was 3.2´ 10- 11 M (Fig. 8B). This value is
close to the EC50 for NT-3 measured in trkC-transfected
fi broblasts or PC12 cells (see, for example, Ip et al., 1993),
and is consistent with our detection of trkC mRNA in E14.5
sympathetic ganglia by in situ hybridization. In turn, the 34-
fold higher EC50that we observe for NT-3 on neonatal SCG
neurons suggests that the NT-3 response is mediated in these
more mature neurons by a receptor other than trkC, perhaps
trkA (Cordon-Cardo et al., 1991). It should be noted that this
low functional dosage sensitivity does not necessarily
indicate the presence of receptors with a low binding affinity
for NT-3, as suggested by recent studies of E11 chick sym-
pathetic neurons (Dechant et al., 1993). Whatever the nature
of the NT-3 receptors on these more mature cells, our data
clearly demonstrate a developmental decline in the NT-3
sensitivity of freshly isolated rat sympathetic neurons and
their precursors, which is well-correlated with a corre-
sponding decline in the expression of trkC mRNA by these
cells in vivo.
DISCUSSION
A central tenet of developmental neurobiology is that
neuronal number is controlled by neurotrophic factors
primarily at the stage when these cells are postmitotic, and
have begun to innervate their targets (Purves and Lichtman,
1985). Here we have shown that mitotically active sympa-
thetic neuroblasts immuno-isolated from early embryos
require NT-3 for survival in a serum-free defined medium.
At t is stage, the cells do not respond to NGF. Later, the
neur blasts become progressively less responsive to NT-3
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Fig. 8.Dose-response characteristics of NT-3 on neonatal and
E14.5 sympathetic neurons. Cell recovery assays were performed
as described above for neonatal SCG neurons (A) and E14.5
sympathetic neuroblasts (B), using NT-3 or NGF. The data points
represent the mean ±s. e. m. of six determinations pooled from
two independent experiments. Note that saturating responses to
NT-3 in neonatal SCG cultures require over 200 ng/ml of factor.
The EC50for NT-3 in A is 1.1´ 0- 9 M, and in B is 3.2´ 10- 11M.
The EC50for NGF in A is 3.2´ 10- 12M. NGF dose-response
profiles were not performed for E14.5 cells because no response to
NGF was obtained even with saturating concentrations of the
factor (Fig. 4A).
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and gain NGF dependence. This change in neurotrophin
responsiveness in vitro is correlated with a reciprocal switch
in neurotrophin receptor mRNA expression in vivo: E14.5
neuroblasts express trkC but not trkA mRNA, while E19.5
neuroblasts express trkA but not trkC mRNAs. Taken
together, these data suggest that neurotrophic factors may
control the number of neurons not only at the time of target
fi eld innervation, as previously thought, but also at earlier
stages of development when these cells are mitotically
active. A corollary to this idea is that the final acquisition of
NGF dependence involves a change in the factor that
supports cell survival, not necessarily a transition from a
neurotrophin-independent to a neurotrophin-dependent
neuron, as originally believed. While it is possible that sym-
pathetic precursors at yet earlier stages are neurotrophin
independent (as reported in chick; see Dechant et al., 1993;
Ernsberger et al., 1989), this model fits well with the
recently expressed idea that many, if not all, cells require
trophic support at all times and that programmed cell death
occurs far more extensively during development than previ-
ously appreciated (Raff, 1992).
Mitogens and trophic factors control sequential
and overlapping stages in sympathetic
development
Previous studies of normal and immortalized rat sympa-
thoadrenal lineage cells have indicated that these cells are
responsive to FGF before they become responsive to NGF
(Stemple et al., 1988; Birren and Anderson, 1990). FGF acts
as both as a differentiation factor, promoting neurite
outgrowth, and as a mitogen for these cells. The B2+sym-
pathetic neuroblasts that we have examined in the present
experiments are already neurite bearing at the time of their
isolation, and therefore do not require FGF for this aspect
of differentiation. Nevertheless these cells continue to
respond to FGF as a strong mitogen (Fig. 5). Despite this
proliferation-promoting activity, however, FGF does not act
as a survival factor for these B2+cells, nor for sympathoa-
drenal progenitors at earlier developmental stages (Birren
and Anderson, 1990; S. Birren, unpublished data). Studies
of FGF protein (Kalcheim and Neufeld, 1990) and mRNA
(D. Stemple and D. Anderson, unpublished) expression in
vivo indicate that this factor is present at a place and time
appropriate for a role in normal sympathetic development.
B2+cells that respond to FGF also respond to NT-3. By
contrast to FGF, however, NT-3 acts primarily as a survival
factor for these neuroblasts, although it may also have
mitogenic effects. A partial mitogenic action for NT-3
would be consistent with a similar action for this factor on
trkC-transfected fibroblasts (Cordon-Cardo et al., 1991).
Studies of NT-3 mRNA expression by in situ hybridization
have revealed that this gene is expressed in rodent sympa-
the ic anglia at stages of development comparable to those
analyz d here (Schecterson and Bothwell, 1992), possibly
in he ganglionic neurons themselves. Such observations are
consistent with an autocrine or paracrine action for this neu-
rotrophin in this context. By contrast, NGF is synthesized
primarily by targets of sympathetic innervation (Davies et
al., 1987; Korsching and Thoenen, 1988). By the time that
sympathetic neurons innervate their targets they are postmi-
t ic, so that NGF does not exert a mitogenic effect on these
cells. However, NGF can act as a mitogen for other prolif-
era ive cells in the sympathoadrenal lineage, such as chro-
maffin cells (Lillien and Claude, 1985) and trkA-transfected
MAH cells (Verdi et al., unpublished data). Taken together,
these data support a model in which growth factors and neu-
rotrophins control sequential and overlapping stages in sym-
pathetic development, with FGF and NT-3 acting locally
within developing ganglia to promote proliferation/differen-
tiation and survival, respectively; and NGF acting as the
ultimate target-derived trophic factor (Fig. 9). The overlap-
ping but distinct effects of these factors on these cells in part
reflects different response pathways at a given stage of
development, and in part developmental changes in a given
respon e pathway.
Other polypeptide factors have been shown to influence
sympathetic neuroblasts at developmental stages compara-
ble to those investigated here (for review, see Rohrer, 1990).
Both insulin-like growth factor-I (IGF-I) and insulin have
been shown to promote thymidine incorporation by prolif-
erating sympathetic neuroblasts (DiCicco-Bloom and Black,
1988, 1989; DiCicco-Bloom et al., 1990). A similar effect
has been observed for vasoactive intestinal polypeptide
(VIP), a neuropeptide synthesized by some sympathetic
neurons (Pincus et al., 1990). Since, in these studies, cell
survival was not examined independent of proliferative
activity, it is difficult to determine whether these factors
indeed act as mitogens, as originally proposed, or whether
they act as survival factors selective for proliferating cells.
In our system, IGF-I and insulin also promoted cell
recovery, although not as efficiently as NT-3 (data not
shown). The presence of these factors in serum could
Fig. 9.Schematic summarizing the action of growth factors at
different stages of sympathoadrenal development.
Sympathetic neuroblasts are initially NGF unresponsive
because they do not express trkA. When these cells initially
express trkA, they become NGF responsive, but are not yet
NGF dependent because they continue to express receptors
for NT-3 (and perhaps other survival factors such as IGF-I).
The cells only become NGF dependent when they lose
receptors for trkC. FGF acts to promote neurite outgrowth and
proliferation, but does not support cell survival in this lineage.
We have not yet determined whether NT-3 acts as a survival
factor for sympathoadrenal progenitors prior to the expression
of the B2 antigen. The factors, if any, that promote the
transitions between these different cell states are not known.
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account for the apparent neurotrophin independence of
embryonic sympathetic neurons observed in previous
studies (Coughlin and Collins, 1985). Recent studies of post-
mitotic chick sympathetic neurons indicated a survival
effect of IGF-I on these cells (H. Rohrer (1993), Soc.
Neurosci. Abstr.). Although the expression of IGF-I and its
receptors in developing sympathetic ganglia have not been
examined in detail, these data raise the possibility that not
only NT-3, but also IGF-I, may act as interim survival
factors for sympathetic neuroblasts. If so, then by analogy
to our results with NT-3 and trkC, the expression of either
IGF-I or its receptor should be down-regulated during sym-
pathetic development to permit predominant control of
neuronal survival by target-derived NGF.
Why have a switch in neurotrophin receptor
expression during development?
Why should developing sympathetic neuroblasts undergo a
developmental switch in neurotrophin responsiveness? If the
ultimate function of neurotrophins is to act as target-derived
survival factors, then at some point developing neurons must
become dependent upon these factors for their survival.
Although such a dependence could be held in abeyance until
the neurons reach their targets (Coughlin and Collins, 1985;
Ernsberger et al., 1989; Vogel and Davies, 1991), another
strategy would be to express a trophic dependence constitu-
tively, but have a different factor support survival until the
target is reached. In that case, in order to achieve predomi-
nant control of neuronal survival by the target-derived neu-
rotrophin, either the neurons must lose access to the interim
survival factor or they must lose the ability to respond to it.
Our data demonstrating a down-regulation of trkC mRNA
coincident with the appearance of trkA mRNA are consis-
tent with the latter explanation, and provide one rationale for
the switch in neurotrophin receptor expression observed.
Another explanation, which we have not formally excluded,
is that the trkC-expressing neurons die and are replaced by
trkA-expressing cells. (However, our E19.5 in vitro data
suggests there is at least some overlap between NT-3-
reponsive and NGF-responsive cells). Whatever the expla-
nation, the data raise the question of whether the reciprocal
expression of trkC and trkA is controlled autonomously or
non-autonomously and, if the latter, what environmental
factors are involved.
Early actions for neurotrophins during neuronal
development
Our data add to a growing body of evidence suggesting that
the actions of neurotrophins are not restricted to target
control of neuronal survival, but extend to earlier stages of
neural development as well. Both NT-3 and BDNF have
been shown to act on undifferentiated avian neural crest
cells in vitro: the former as a mitogen (Kalcheim et al.,
1992); the latter as a possible instructive signal for sensory
neuron differentiation (Sieber-Blum, 1991). Dechant et al.
(1993) recently reported that some E7 chick sympathetic
neurons developed a response to NT-3 after 7 days in vitro
(although freshly isolated E7 neurons did not respond to low
concentrations of the neurotrophin). BDNF and NT-3 have
been shown to act on progenitor cells in the developing cere-
bellum (Segal et al., 1992) and hippocampus (Collazo et al.,
1992), as assessed by increased cell recovery in dissociated
cultures and induction of c-fosimmunoreactivity in cultured
slices. However, the precise biological action (mitogen,
r i l factor) of these factors was not assessed in these
studies, nor was the distribution of receptor expression
examined in vivo. Nevertheless these studies collectively
raised the notion that neurotrophins do not act simply as
survival factors for differentiated, postmitotic neurons, but
also act on proliferating neuroepithelial progenitor cells as
well. The idea that a given growth factor may exert different
act ons on developing cells at different stages in a given
lineage is well accepted in the field of hematopoiesis, from
studies of factors such as erythropoietin (Metcalf, 1989).
Our results also support the general concept that different
members of the neurotrophin family may act at different
stages within a given neurogenic lineage. The culture exper-
iments mentioned above suggested a sequential action of
NT-3 and BDNF in cerebellar granule cell development
(Segal t al., 1992). Studies of cultured avian sensory
neurons have revealed that the maturation of these postmi-
totic cells is promoted by BDNF (and possibly NT-3) before
they become NGF dependent, although the former appar-
ently do not act as survival factors (Wright et al., 1992).
While we have also examined a possible role for BDNF, the
results are less compelling: trkB mRNA was not expressed
in ganglionic neuroblasts in vivo, and BDNF had only weak
a d irreproducible effects on the recovery of E14.5 B2+cells
in vitro (data not shown). Our data support a sequential
action for NT-3 and NGF as survival factors in sympathetic
neuron development, and further suggest that a progressive
loss f NT-3 sensitivity may occur as NGF responsiveness
is acquired.
Our dose-response data indicate that neonatal rat sympa-
thetic neurons are far less sensitive to NT-3 than their
embryonic precursors. The EC50for NT-3 is similar to that
recently reported for E11 chick sympathetic neurons
(Dechant et al., 1993). These data may explain why some
previous assays, utilizing high concentrations of the factor
(approx. 60 ng/ml), detected responses in embryonic chick
sym thetic neurons (Ernfors et al., 1990; Maisonpierre et
al., 1990b; Rosenthal et al., 1990), whereas others utilizing
low c ncentrations (approx. 1 ng/ml) did not (Hohn et al.,
1990). Beyond reconciling these discrepancies, our data
suggest that unless very high concentrations of NT-3 are
achieved in vivo, the contribution of this factor to the trophic
support of neonatal sympathetic neurons may be negligible.
On the other hand, during prenatal development, NT-3 may
play a crucial role in controlling neuroblast number locally
in developing ganglia, before the neurons become dependent
upon target-derived NGF (Schecterson and Bothwell, 1992).
Definitive tests of the relative trophic influences of NT-3 and
NGF at different developmental stages are now possible, in
principle, through gene knockout experiments in the mouse.
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